PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

Recruiting now

Conditions studied: Pre-eclampsia, Oocyte Donation, Pre-Eclampsia; Complicating Pregnancy, Pre-Eclampsia; Mild, Pre-Eclampsia, Severe, Pre-eclampsia or Eclampsia With Pre-existing Hypertension, ART, Neonatal Morbidity, Neonatal Mortality, Placental Abruption, Gestational Diabetes, Preterm Labor, Post-partum Hemorrhage (PPH), Intrauterine Growth Restriction (IUGR), Hypertensive Disorders of Pregnancy

In brief

The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes. Participants will be followed throughout pregnancy with blood samples, blood pressure, clinical controls and ultrasound examinations. Clinical outcomes will be registered post-partum.

Key facts

Study ID
NCT07263490
Run by
Copenhagen University Hospital, Hvidovre
People needed
462
Starts
2024-10-21
Expected to finish
2028-06-01
Last updated by the study team
2026-04-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.